Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2017 Filed Mar 23, 2017 14:18 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 1,000 | $6.64 | $6,640.00 |
DisclosureSEC source: 0001209191-17-022501 · doc4.xml · nonDerivative · entry 5 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 1,285 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 14:18 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 500 | $6.63 | $3,315.00 |
DisclosureSEC source: 0001209191-17-022501 · doc4.xml · nonDerivative · entry 4 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 11,825 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 14:18 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 3,951 | $6.60 | $26,076.60 |
DisclosureSEC source: 0001209191-17-022501 · doc4.xml · nonDerivative · entry 3 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 11,325 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 14:18 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 1,054 | $6.55 | $6,903.70 |
DisclosureSEC source: 0001209191-17-022501 · doc4.xml · nonDerivative · entry 2 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 7,374 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 14:18 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 476 | $6.50 | $3,094.00 |
DisclosureSEC source: 0001209191-17-022501 · doc4.xml · nonDerivative · entry 1 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 6,320 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 19:56 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 200 | $6.69 | $1,338.00 |
DisclosureSEC source: 0001209191-17-022013 · doc4.xml · nonDerivative · entry 5 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 5,844 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 19:56 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 3,400 | $6.70 | $22,780.00 |
DisclosureSEC source: 0001209191-17-022013 · doc4.xml · nonDerivative · entry 4 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 5,644 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 19:56 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 500 | $6.68 | $3,340.00 |
DisclosureSEC source: 0001209191-17-022013 · doc4.xml · nonDerivative · entry 3 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 2,244 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 19:56 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 1,644 | $6.65 | $10,932.60 |
DisclosureSEC source: 0001209191-17-022013 · doc4.xml · nonDerivative · entry 2 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 1,744 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 19:56 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 100 | $6.60 | $660.00 |
DisclosureSEC source: 0001209191-17-022013 · doc4.xml · nonDerivative · entry 1 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 100 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 13:52 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 40 | $6.40 | $256.00 |
DisclosureSEC source: 0001209191-17-020734 · doc4.xml · nonDerivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,867,170 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 13:52 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 88 | $6.45 | $567.60 |
DisclosureSEC source: 0001209191-17-020734 · doc4.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,867,130 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 13:52 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 2,372 | $6.50 | $15,418.00 |
DisclosureSEC source: 0001209191-17-020734 · doc4.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,867,042 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 12:03 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 47 | $6.35 | $298.45 |
DisclosureSEC source: 0001209191-17-020060 · doc4.xml · nonDerivative · entry 8 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,864,670 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 12:03 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 66 | $6.40 | $422.40 |
DisclosureSEC source: 0001209191-17-020060 · doc4.xml · nonDerivative · entry 7 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,864,623 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 12:03 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 200 | $6.45 | $1,290.00 |
DisclosureSEC source: 0001209191-17-020060 · doc4.xml · nonDerivative · entry 6 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,864,557 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 12:03 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 900 | $6.50 | $5,850.00 |
DisclosureSEC source: 0001209191-17-020060 · doc4.xml · nonDerivative · entry 5 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,864,357 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 12:03 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 100 | $6.35 | $635.00 |
DisclosureSEC source: 0001209191-17-020060 · doc4.xml · nonDerivative · entry 4 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,863,457 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 12:03 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 300 | $6.45 | $1,935.00 |
DisclosureSEC source: 0001209191-17-020060 · doc4.xml · nonDerivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,863,357 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 12:03 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 500 | $6.40 | $3,200.00 |
DisclosureSEC source: 0001209191-17-020060 · doc4.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,863,057 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 12:03 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 1,600 | $6.50 | $10,400.00 |
DisclosureSEC source: 0001209191-17-020060 · doc4.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,862,557 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 10:53 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 600 | $6.45 | $3,870.00 |
DisclosureSEC source: 0001209191-17-019498 · doc4.xml · nonDerivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,860,957 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 10:53 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 1,900 | $6.50 | $12,350.00 |
DisclosureSEC source: 0001209191-17-019498 · doc4.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,860,357 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 07, 2017 Filed Mar 9, 2017 10:53 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 2,200 | $6.50 | $14,300.00 |
DisclosureSEC source: 0001209191-17-019498 · doc4.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,858,457 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 10:12 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 1,000 | $6.40 | $6,400.00 |
DisclosureSEC source: 0001209191-17-015608 · doc4.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,856,257 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 10:12 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 1,500 | $6.50 | $9,750.00 |
DisclosureSEC source: 0001209191-17-015608 · doc4.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,855,257 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 15:31 UTC |
Inayatullah Arif10% owner
|
GrantEmployee Stock Option · Derivative | 219,472 | $0.00 Strike: $6.65 | $0.00 |
DisclosureSEC source: 0001209191-17-016466 · doc4.xml · derivative · entry 3 Inayatullah Arif · CIK 0001499674 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By: Tricadia Holdings, L.P. Disclosed balance after: 319,967 Underlying: Class A Common Stock · 219,472 shares Expires not disclosed F3 · security: In consideration of Michael Barnes' services to the Registrant, Tricadia was granted stock options to purchase 219,472 shares of common stock of the Registrant subject to the terms of a Stock Option Agreement among the Registrant, Michael Barnes and Tricadia (the "Stock Option"). F4 · shares: Exercise of the Stock Option is subject to both (1) a time-based vesting requirement with one-third vesting each of February 22, 2020, 2021 and 2022 and (2) a performance-based vesting requirement that, at any time during the option term, achievement of a 20-day volume weighted average stock price of Registrant's Class A Common Stock, that exceeds the per share book value on an as exchanged basis as of December 31, 2016 (as reported in the Registrant's filings with the Securities and Exchange Commission). F4 · derivative.exercise_date: Exercise of the Stock Option is subject to both (1) a time-based vesting requirement with one-third vesting each of February 22, 2020, 2021 and 2022 and (2) a performance-based vesting requirement that, at any time during the option term, achievement of a 20-day volume weighted average stock price of Registrant's Class A Common Stock, that exceeds the per share book value on an as exchanged basis as of December 31, 2016 (as reported in the Registrant's filings with the Securities and Exchange Commission). F5 · derivative.expiration_date: The Stock Option will expire on the earlier of (1) February 22, 2027 and (2) the date of the termination of Michael Barnes's service with the Registrant for Cause (as defined in the Stock Option Agreement) or Michael Barnes's voluntary termination of service with the Registrant. F2 · ownership.direct: The reporting person is a principal of Tricadia Holdings, L.P. ("Tricadia") The number of shares reflects a total which is greater than the Reporting Person's pecuniary interest. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 15:31 UTC |
Inayatullah Arif10% owner
|
GrantClass A Common Stock | 109,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016466 · doc4.xml · nonDerivative · entry 1 Inayatullah Arif · CIK 0001499674 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By: Tricadia Holdings, L.P. Disclosed balance after: 159,983 F1 · shares: In consideration of Michael Barnes' services to the Registrant, Tricadia was granted restricted stock units, which represent the right to receive shares of the Registrant's Class A Common Stock, pursuant to the Registrant's Equity Plan. The restricted stock units are subject to cliff vesting on February 22, 2020 upon continuous employment of Michael Barnes from the grant date until such date, subject to certain terms contained in a restricted stock unit award agreement among the Registrant, Michael Barnes and Tricadia. F2 · ownership.direct: The reporting person is a principal of Tricadia Holdings, L.P. ("Tricadia") The number of shares reflects a total which is greater than the Reporting Person's pecuniary interest. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 20:35 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
GrantEmployee Stock Option · Derivative | 351,155 | $0.00 Strike: $6.65 | $0.00 |
DisclosureSEC source: 0001209191-17-016472 · doc4.xml · derivative · entry 1 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 501,897 Underlying: Class A Common Stock · 351,155 shares Expires not disclosed F1 · security: The Reporting Person was granted non-qualified stock options to purchase 351,155 shares of common stock of the Registrant, subject to the terms of a Stock Option Agreement between the Registrant and the Reporting person (the "Stock Option Agreement"). F2 · shares: Exercise of the Stock Option is subject to both (1) a time-based vesting requirement with one-third vesting each of February 22, 2020, 2021 and 2022 and (2) a performance-based vesting requirement that, at any time during the option term, achievement of a 20-day volume weighted average stock price of Registrant's Class A Common Stock, that exceeds the per share book value on an as exchanged basis as of December 31, 2016 (as reported in the Registrant's filings with the Securities and Exchange Commission). F2 · derivative.exercise_date: Exercise of the Stock Option is subject to both (1) a time-based vesting requirement with one-third vesting each of February 22, 2020, 2021 and 2022 and (2) a performance-based vesting requirement that, at any time during the option term, achievement of a 20-day volume weighted average stock price of Registrant's Class A Common Stock, that exceeds the per share book value on an as exchanged basis as of December 31, 2016 (as reported in the Registrant's filings with the Securities and Exchange Commission). F3 · derivative.expiration_date: The Stock Option will expire on the earlier of (1) February 22, 2027 and (2) the date of the termination of Jonathan Ilany's service with the Registrant for Cause (as defined in the Stock Option Agreement) or Jonathan Ilany's voluntary termination of service with the Registrant. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 15:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
GrantEmployee Stock Option · Derivative | 219,472 | $0.00 Strike: $6.65 | $0.00 |
DisclosureSEC source: 0001209191-17-016465 · doc4.xml · derivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By: Tricadia Holdings, L.P. Disclosed balance after: 319,967 Underlying: Class A Common Stock · 219,472 shares Expires not disclosed F2 · security: In consideration of Michael Barnes' services to the Registrant, Tricadia was granted stock options to purchase 219,472 shares of common stock of the Registrant subject to the terms of a Stock Option Agreement among the Registrant, Michael Barnes and Tricadia (the "Stock Option"). F3 · shares: Exercise of the Stock Option is subject to both (1) a time-based vesting requirement with one-third vesting each of February 22, 2020, 2021 and 2022 and (2) a performance-based vesting requirement that, at any time during the option term, achievement of a 20-day volume weighted average stock price of Registrant's Class A Common Stock, that exceeds the per share book value on an as exchanged basis as of December 31, 2016 (as reported in the Registrant's filings with the Securities and Exchange Commission). F3 · derivative.exercise_date: Exercise of the Stock Option is subject to both (1) a time-based vesting requirement with one-third vesting each of February 22, 2020, 2021 and 2022 and (2) a performance-based vesting requirement that, at any time during the option term, achievement of a 20-day volume weighted average stock price of Registrant's Class A Common Stock, that exceeds the per share book value on an as exchanged basis as of December 31, 2016 (as reported in the Registrant's filings with the Securities and Exchange Commission). F4 · derivative.expiration_date: The Stock Option will expire on the earlier of (1) February 22, 2027 and (2) the date of the termination of Michael Barnes's service with the Registrant for Cause (as defined in the Stock Option Agreement) or Michael Barnes's voluntary termination of service with the Registrant. F5 · ownership.direct: The reporting person is a principal of Tricadia Holdings, L.P. ("Tricadia"). The number of shares reflects a total which is greater than the Reporting Person's pecuniary interest. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 15:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
GrantClass A Common Stock | 109,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016465 · doc4.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By: Tricadia Holdings, L.P. Disclosed balance after: 159,983 F1 · shares: In consideration of Michael Barnes' services to the Registrant, Tricadia was granted restricted stock units, which represent the right to receive shares of the Registrant's Class A Common Stock, pursuant to the Registrant's Equity Plan. The restricted stock units are subject to cliff vesting on February 22, 2020 upon continuous employment of Michael Barnes from the grant date until such date, subject to certain terms contained in a restricted stock unit award agreement among the Registrant, Michael Barnes and Tricadia. F1 · ownership.direct: In consideration of Michael Barnes' services to the Registrant, Tricadia was granted restricted stock units, which represent the right to receive shares of the Registrant's Class A Common Stock, pursuant to the Registrant's Equity Plan. The restricted stock units are subject to cliff vesting on February 22, 2020 upon continuous employment of Michael Barnes from the grant date until such date, subject to certain terms contained in a restricted stock unit award agreement among the Registrant, Michael Barnes and Tricadia. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 15:39 UTC |
Bell SandraChief Financial Officer
|
GrantClass A Common Stock | 19,670 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016478 · doc4.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,657 F1 · shares: The Reporting Person was granted restricted stock units, which represent the right to receive shares of the Issuer's Class A Common Stock, pursuant to the Issuer's Equity Plan. The restricted stock units will vest annually in three equal installments on each of February 22, 2018, February 22, 2019 and February 22, 2020 upon continuous employment from the grant date until such date, subject to certain terms contained in the Reporting Person's award agreement. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 12:51 UTC |
Rifkind Neil CharlesGeneral Counsel and Secretary
|
GrantClass A Common Stock | 20,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016343 · doc4.xml · nonDerivative · entry 1 Rifkind Neil Charles · CIK 0001580685 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,462 F1 · shares: The Reporting Person was granted restricted stock units, which represent the right to receive shares of the Issuer's Class A Common Stock, pursuant to the Issuer's Equity Plan. The restricted stock units will vest annually in three equal installments on each of February 22, 2018, February 22, 2019 and February 22, 2020 upon continuous employment from the grant date until such date, subject to certain terms contained in the Reporting Person's award agreement. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 11:39 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 24 | $6.45 | $154.80 |
DisclosureSEC source: 0001209191-17-013638 · doc4.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,853,757 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 11:39 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 1,600 | $6.50 | $10,400.00 |
DisclosureSEC source: 0001209191-17-013638 · doc4.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,853,733 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 11:34 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 100 | $6.43 | $643.00 |
DisclosureSEC source: 0001209191-17-012519 · doc4.xml · nonDerivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,852,133 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 11:34 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 410 | $6.40 | $2,624.00 |
DisclosureSEC source: 0001209191-17-012519 · doc4.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,852,033 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 11:34 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 1,990 | $6.45 | $12,835.50 |
DisclosureSEC source: 0001209191-17-012519 · doc4.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,851,623 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 10:25 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 1,000 | $6.45 | $6,450.00 |
DisclosureSEC source: 0001209191-17-011849 · doc4.xml · nonDerivative · entry 4 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,849,633 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 10:25 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 1,500 | $6.40 | $9,600.00 |
DisclosureSEC source: 0001209191-17-011849 · doc4.xml · nonDerivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,848,633 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 10:25 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 200 | $6.45 | $1,290.00 |
DisclosureSEC source: 0001209191-17-011849 · doc4.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,847,133 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 10:25 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 800 | $6.40 | $5,120.00 |
DisclosureSEC source: 0001209191-17-011849 · doc4.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,846,933 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 12:10 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 700 | $6.40 | $4,480.00 |
DisclosureSEC source: 0001209191-17-010963 · doc4.xml · nonDerivative · entry 6 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,846,133 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 12:10 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 1,600 | $6.35 | $10,160.00 |
DisclosureSEC source: 0001209191-17-010963 · doc4.xml · nonDerivative · entry 5 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,845,433 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 12:10 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 100 | $6.35 | $635.00 |
DisclosureSEC source: 0001209191-17-010963 · doc4.xml · nonDerivative · entry 4 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,843,833 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 12:10 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 200 | $6.50 | $1,300.00 |
DisclosureSEC source: 0001209191-17-010963 · doc4.xml · nonDerivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,843,733 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 12:10 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 800 | $6.40 | $5,120.00 |
DisclosureSEC source: 0001209191-17-010963 · doc4.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,843,533 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 12:10 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 1,400 | $6.45 | $9,030.00 |
DisclosureSEC source: 0001209191-17-010963 · doc4.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,842,733 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 09:42 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 100 | $6.35 | $635.00 |
DisclosureSEC source: 0001209191-17-009836 · doc4.xml · nonDerivative · entry 9 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,841,333 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 09:42 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseClass A Common Stock | 100 | $6.20 | $620.00 |
DisclosureSEC source: 0001209191-17-009836 · doc4.xml · nonDerivative · entry 8 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,841,233 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.